Published June 12, 2024
| Version v1
Dataset
Restricted
The Anonymized Data of H56 POR Clinical Trial
Description
This dataset is derived from "A Phase 2, Double-blind, Randomised, Placebo-Controlled Study to Evaluate the Safety and Efficacy of H56:IC31® in Reducing the Rate of TB Disease Recurrence in HIV Negative Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis" (ClinicalTrials.gov number: NCT03512249).
The results have been reported in The Lancet Infectious Diseases (https://doi.org/10.1016/S1473-3099(24)00814-4)
To request access to the data, please contact Tu Hu at tuhu@ssi.dk.
Files
Additional details
Related works
- Is supplement to
- Journal article: 10.1016/S1473-3099(24)00814-4 (DOI)